Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
Frontiers in Veterinary Science|October 8, 2024
Bacteriophage P2-71: a promising therapeutic against multidrug-resistant Proteus mirabilis in urinary tract infectionsRuihu Wu, Zhiyou Dong, Yunjiang Liu, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
Tailoring Escalation Adjuvant Therapy for Early-Stage Triple-Negative Breast Cancer in the CBCSG010 Clinical Trial Biomarker AnalysisWenya Wu, Yunsong Yang, Wentao Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2019
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II StudyFei Ma, Quchang Ouyang, Wei Li, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2023
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in ChinaBinghe Xu, Huiping Li, Zefei Jiang, et al.Frontiers in Oncology|November 17, 2022
The value of hsa_circ_0058514 in plasma extracellular vesicles for breast cancerJiani Liu, Xinyu Peng, Yang Yang, et al.Scientific Reports|April 8, 2021
The beneficial role of Asian-based RecurIndex test in the prognostic prediction in Chinese male breast cancer patientsShuo Zhang, Beichen Liu, Mengli Zhou, et al.Nature Communications|June 17, 2024
HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trialQiao Li, Ying Cheng, Zhongsheng Tong, et al.BMC Medicine|December 27, 2022
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trialJiong Wu, Zefei Jiang, Zhenzhen Liu, et al.BMC Medicine|October 8, 2025
Safety and tolerability of bireociclib for the treatment of advanced solid tumors as monotherapy and in combination with endocrine therapy: a multicenter, open-label, phase 1 clinical trialJiayu Wang, Tao Sun, Zhongsheng Tong, et al.Iscience|July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world studyFengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.Pageof 10